Skip to main content

Table 1 Demographics and clinical characteristics

From: Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial

Characteristic

Exp. (n = 21)

Cont. (n = 19)

χ2/t (p)

Mean ± SD (range)

N (%)

Mean ± SD (range)

N (%)

Age (years)

49.86 ± 7.9 (34–67)

47.63 ± 6.96 (33–58)

.937(.355)

 30–39

1 (4.8)

2 (10.5)

2.573 (.462)

 40–49

10 (47.6)

11 (57.9)

 

 50–59

8 (38.1)

6 (31.6)

 

 60–69

2 (9.5)

0 (0)

 

Marital status

 Married

15 (71.4)

12 (63.2)

.311(.577)

 Unmarried

6 (28.6)

7 (36.8)

 

Monthly income, 10,000 KRW

  < 300 ($2,660)

11 (52.4)

9 (47.4)

.100 (.752)

  ≥ 300 ($2,660)

10 (47.6)

10 (52.6)

 

(USD dollars)

 Employment status

  No

15 (71.4)

10 (52.6)

1.503(.220)

  Yes

6 (28.6)

9 (47.4)

 

 Education level

   < Middle school

1 (4.8)

1 (5.3)

3.713(.156)

  High school

14 (66.6)

7 (36.8)

 

   ≥ College

6 (28.6)

11 (57.9)

 

 Children

  No

5 (23.8)

4 (21.1)

.043(.835)

  Yes

16 (76.2)

15 (78.9)

 

 Stage

  I

5 (23.8)

5 (26.3)

1.744(.418)

  II

12 (57.1)

13 (68.4)

 

  III

4 (19)

1 (5.3)

 

 Surgery type

  Mastectomy

4 (19)

5 (26.3)

.302 (.583)

  Lumpectomy

17 (81)

14 (73.7)

 

 Time since diagnosis

   < 1 year

8 (38.1)

8 (42.1)

.575(.750)

  1–2 years

11 (52.4)

8 (42.1)

 

   ≥ 2 years

2 (9.5)

3 (15.8)

 

 Chemotherapy

  None

0 (0)

1 (5.3)

1.134(.287)

  Past

21 (100)

18 (94.7)

 

 Radiation therapy

  None

1 (4.8)

3 (15.8)

1.206(.235)

  Past

20 (95.2)

16 (84.2)

 

 Endocrine therapy

  No

9 (42.9)

8 (42.1)

.002(.962)

  Yes

12 (57.1)

11 (57.9)

 

 Targeted therapy

  No

10 (47.6)

15 (78.9)

4.483(.106)

  Yes

10 (47.6)

4 (21.1)

 

  Unknown

1 (4.8)

0 (0.0)

 
  1. Abbreviations: Cont Control group, Exp Experimental group, KRW Korean won (1160 KRW = approximately 1 US)